Experts see chance for Covid-19 vaccine approval this fall — if done right
Here is how a fast approval might play out, if all goes well — and some warning signs that normal procedure is not being followed.
Here is how a fast approval might play out, if all goes well — and some warning signs that normal procedure is not being followed.
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
A House subcommittee investigating the “lab leak” theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan and pushes to deny it…
An experimental gene therapy seems to alleviate skeletal defects tied to rare inherited disease, a new study shows.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
Sen. Edward Markey (D-Mass.) spoke at a STAT event about how his bill is garnering bipartisan support to improve access to the opioid treatment.
Eli Lilly raised its full-year guidance while it reported strong first-quarter sales of Zepbound, its obesity drug.